BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 21704588)

  • 21. YAP1-mediated pancreatic stellate cell activation inhibits pancreatic cancer cell proliferation.
    Xiao Y; Zhang H; Ma Q; Huang R; Lu J; Liang X; Liu X; Zhang Z; Yu L; Pang J; Zhou L; Liu T; Wu H; Liang Z
    Cancer Lett; 2019 Oct; 462():51-60. PubMed ID: 31352078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic autophagy blockade and VDR signaling activation enhance stellate cell reprogramming in pancreatic ductal adenocarcinoma.
    Kong W; Liu Z; Sun M; Liu H; Kong C; Ma J; Wang R; Qian F
    Cancer Lett; 2022 Jul; 539():215718. PubMed ID: 35526650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Galectin-1-driven upregulation of SDF-1 in pancreatic stellate cells promotes pancreatic cancer metastasis.
    Qian D; Lu Z; Xu Q; Wu P; Tian L; Zhao L; Cai B; Yin J; Wu Y; Staveley-O'Carroll KF; Jiang K; Miao Y; Li G
    Cancer Lett; 2017 Jul; 397():43-51. PubMed ID: 28336327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of Cancer-Associated Fibrotic Stroma by An Integrin α
    Turaga RC; Sharma M; Mishra F; Krasinskas A; Yuan Y; Yang JJ; Wang S; Liu C; Li S; Liu ZR
    Cell Mol Gastroenterol Hepatol; 2021; 11(1):161-179. PubMed ID: 32810598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ATRA modulates mechanical activation of TGF-β by pancreatic stellate cells.
    Sarper M; Cortes E; Lieberthal TJ; Del Río Hernández A
    Sci Rep; 2016 Jul; 6():27639. PubMed ID: 27375161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor effects of all-trans retinoic acid and its synergism with gemcitabine are associated with downregulation of p21-activated kinases in pancreatic cancer.
    Wang K; Baldwin GS; Nikfarjam M; He H
    Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G632-G640. PubMed ID: 30844294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic stellate cells exploit Wnt/β-catenin/TCF7-mediated glutamine metabolism to promote pancreatic cancer cells growth.
    Liu H; Zhang H; Liu X; Guo W; Liu Q; Chen L; Pang J; Liu X; Li R; Tong WM; Wu H; Dai M; Liang Z
    Cancer Lett; 2023 Feb; 555():216040. PubMed ID: 36565920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic stellate cell: Pandora's box for pancreatic disease biology.
    Bynigeri RR; Jakkampudi A; Jangala R; Subramanyam C; Sasikala M; Rao GV; Reddy DN; Talukdar R
    World J Gastroenterol; 2017 Jan; 23(3):382-405. PubMed ID: 28210075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activated leukocyte cell adhesion molecule regulates the interaction between pancreatic cancer cells and stellate cells.
    Zhang WW; Zhan SH; Geng CX; Sun X; Erkan M; Kleeff J; Xie XJ
    Mol Med Rep; 2016 Oct; 14(4):3627-33. PubMed ID: 27573419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrin α11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancer.
    Schnittert J; Bansal R; Mardhian DF; van Baarlen J; Östman A; Prakash J
    FASEB J; 2019 May; 33(5):6609-6621. PubMed ID: 30808244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1.
    Geleta B; Tout FS; Lim SC; Sahni S; Jansson PJ; Apte MV; Richardson DR; Kovačević Ž
    J Biol Chem; 2022 Mar; 298(3):101608. PubMed ID: 35065073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PITX2 in pancreatic stellate cells promotes EMT in pancreatic cancer cells via the Wnt/β-catenin pathway.
    Wu D; Chen W; Yang Y; Qin Y; Zu G; Zhang Y; An Y; Sun D; Xu X; Chen X
    Acta Biochim Biophys Sin (Shanghai); 2023 Jun; 55(9):1393-1403. PubMed ID: 37337632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bisphosphonates inhibit stellate cell activity and enhance antitumor effects of nanoparticle albumin-bound paclitaxel in pancreatic ductal adenocarcinoma.
    Gonzalez-Villasana V; Rodriguez-Aguayo C; Arumugam T; Cruz-Monserrate Z; Fuentes-Mattei E; Deng D; Hwang RF; Wang H; Ivan C; Garza RJ; Cohen E; Gao H; Armaiz-Pena GN; Del C Monroig-Bosque P; Philip B; Rashed MH; Aslan B; Erdogan MA; Gutierrez-Puente Y; Ozpolat B; Reuben JM; Sood AK; Logsdon C; Lopez-Berestein G
    Mol Cancer Ther; 2014 Nov; 13(11):2583-94. PubMed ID: 25193509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paracrine SDF-1α signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells.
    Zhang H; Wu H; Guan J; Wang L; Ren X; Shi X; Liang Z; Liu T
    Oncotarget; 2015 Feb; 6(5):3085-97. PubMed ID: 25609203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.
    Fu Y; Liu S; Zeng S; Shen H
    Mol Cancer; 2018 Feb; 17(1):62. PubMed ID: 29458370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
    Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EYA4 functions as tumor suppressor gene and prognostic marker in pancreatic ductal adenocarcinoma through β-catenin/ID2 pathway.
    Mo SJ; Liu X; Hao XY; Chen W; Zhang KS; Cai JP; Lai JM; Liang LJ; Yin XY
    Cancer Lett; 2016 Oct; 380(2):403-412. PubMed ID: 27378242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FAM84B, amplified in pancreatic ductal adenocarcinoma, promotes tumorigenesis through the Wnt/β-catenin pathway.
    Zhang X; Xu J; Yan R; Zhang Y; Hu Z; Fu H; You Q; Cai Q; Yang D
    Aging (Albany NY); 2020 Apr; 12(8):6808-6822. PubMed ID: 32291380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro.
    Xu J; Liu S; Yang X; Cao S; Zhou Y
    Life Sci; 2020 Dec; 263():118523. PubMed ID: 33039386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting of the P2X7 receptor in pancreatic cancer and stellate cells.
    Giannuzzo A; Saccomano M; Napp J; Ellegaard M; Alves F; Novak I
    Int J Cancer; 2016 Dec; 139(11):2540-52. PubMed ID: 27513892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.